{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-034216","form_type":"8-K","ticker":"GEN","cik":"0000849399","company_name":"Gen Digital Inc.","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.030060+00:00","generated_at":"2026-06-26T22:33:38.733279+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"UK CMA refers NortonLifeLock-Avast merger to Phase 2; closing delayed to mid-late 2022","bullets":["UK Competition and Markets Authority intends to refer merger to Phase 2 investigation unless remedies offered.","NortonLifeLock says decision is surprising, will not propose Phase 1 remedies, will engage constructively.","Merger timeline delayed to mid-to-late 2022; previously expected to close earlier.","US DoJ, German Federal Cartel Office, and Spanish CNMC have cleared the transaction; UK CMA is only outstanding.","NortonLifeLock remains confident the transaction should be approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-034216","json":"https://secwatch.observer/filing/0001104659-22-034216.json","markdown":"https://secwatch.observer/filing/0001104659-22-034216.md","text":"https://secwatch.observer/filing/0001104659-22-034216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849399/000110465922034216/0001104659-22-034216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849399/000110465922034216/tm229447d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:33:38.733279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}